Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Microneedle Array Alone Clear all

Conditions: Chronic Pain
Interventions: A-Band (Smart Band-Aid), Empatica Smartwatch, Questionnaires: Hospital Anxiety & Depression Scale, Central Sensitization Inventory, Pain Catastrophizing Scale, Somatic Symptom Scale-8, Pain Self-Efficacy Questionnaire-10, Athens Insomnia Scale; Device · Combination Product · Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Bethesda, Maryland

Conditions: Overweight and/or Obesity
Interventions: VX-201, semaglutide SC; Combination Product · Drug
Lead sponsor: Terrestrial Bio, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Rotavirus Infections
Interventions: 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV), 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV), Placebo; Biological · Other
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years to 45 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes
Interventions: Microneedle patch, Intravenous (IV) catheter, Lancet; Device
Lead sponsor: Emory University; Other
Eligibility: 7 Years to 18 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Acute Migraine
Interventions: ZP-Zolmitriptan, Placebo; Drug
Lead sponsor: Zosano Pharma Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 365 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 36
States / cities: Glendale, Arizona • Carlsbad, California • Huntington Beach, California + 32 more

Conditions: Vaccination, Skin Absorption
Interventions: Microneedle Formulation 1, Microneedle Formulation 2; Device
Lead sponsor: Emory University; Other
Eligibility: 6 Weeks to 24 Months
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma
Interventions: Microneedle Array Doxorubicin (MNA-D); Drug
Lead sponsor: Falo, Louis, MD; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy
Interventions: Microneedle patch; Device
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 50 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Healthy
Interventions: Vacuum-Assisted Microneedle Device; Device
Lead sponsor: Sharon Pitteri; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Stanford, California

Conditions: Nodular Basal Cell Carcinoma
Interventions: D-MNA 200µg, D-MNA 100µg, Microneedle Array Alone; Drug · Other
Lead sponsor: SkinJect, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 10
States / cities: Fresno, California • San Diego, California • Naperville, Illinois + 6 more

Conditions: Cluster Headache
Interventions: C213 Microneedle System, Placebo; Drug
Lead sponsor: Zosano Pharma Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 12
States / cities: Los Angeles, California • Palo Alto, California • Santa Monica, California + 9 more

Conditions: Healthy
Interventions: Micropatch (microneedle patch); Other
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 45 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Osteoporosis
Interventions: abaloparatide-sMTS (Patheon), abaloparatide-sMTS (Kindeva); Combination Product
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cutaneous T Cell Lymphoma
Interventions: Micro needle array-Doxorubicin (MNA-D); Drug
Lead sponsor: Falo, Louis, MD; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Postmenopausal Osteoporosis
Interventions: abaloparatide, abaloparatide solid microstructured transdermal system; Combination Product
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 50 Years to 85 Years · Female only
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 77
States / cities: Birmingham, Alabama • Anchorage, Alaska • Glendale, Arizona + 65 more

Search by objective public record fields.

ARPA-H Smart Band-Aid to Measure Chronic Pain in Women

Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

Glucose Measurement Using Microneedle Patches

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

Microneedle Patch Study in Healthy Infants/Young Children

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Racial/Ethnic Differences in Microneedle Response

Study of Dermal Interstitial Fluid Collection With a Vacuum-Assisted Microneedle Device

Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.

Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches

Visualizing Dermal Micropores With OCT

Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.

Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)

Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis